ELIEM THERAPEUTICS INC (ELYM) Institutional Shareholders
ELIEM THERAPEUTICS INC (ELYM) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $734.01M in ELYM holdings during the latest filing period.
Ra Capital Management, L.P. is currently the largest disclosed institutional shareholder of ELYM tracked by InsiderSet, reporting ownership valued at approximately $147.36M in its June 30, 2026 SEC Form 13F filing.
The top 10 institutional shareholders tracked on this page collectively account for approximately 66% of the total disclosed ELYM value among the investors covered in this analysis. Major shareholders include Ra Capital Management, L.P., Fmr Llc, Ubs Group Ag, and several other long-term asset managers with concentrated positions in ELIEM THERAPEUTICS INC (ELYM).
This page ranks the largest institutional ELYM shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
106
Total Reported Value
$734.01M
Largest Holder
Ra Capital Management, L.P.
Largest Position
$147.36M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
138
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 1.28% | 11,300,939 | $147,364,245 | — | — | — | |
| Fmr Llc | 0.00% | 6,790,364 | $88,546,347 | — | — | — | |
| Ubs Group Ag | 0.01% | 3,404,866 | $44,399,453 | — | — | — | |
| Braidwell Lp | 1.35% | 2,797,375 | $36,477,770 | — | — | — | |
| Adage Capital Partners Gp, L.L.C. | 0.05% | 2,506,000 | $32,678,240 | — | — | — | |
| Blackrock, Inc. | 0.00% | 2,354,872 | $30,707,531 | — | — | — | |
| Price T Rowe Associates Inc | 0.00% | 2,127,281 | $27,741,000 | — | — | — | |
| Cormorant Asset Management, Lp | 1.41% | 2,106,000 | $27,462,240 | — | — | — | |
| Frontier Capital Management Co Llc | 0.24% | 1,939,019 | $25,284,808 | — | — | — | |
| Vanguard Capital Management Llc | 0.00% | 1,698,654 | $22,150,448 | — | — | — | |
| Woodline Partners Lp | 0.06% | 1,582,291 | $20,633,075 | — | — | — | |
| Citadel Advisors Llc | 0.01% | 1,297,972 | $16,925,555 | — | — | — | |
| Redmile Group, Llc | 1.07% | 1,226,330 | $15,991,343 | — | — | — | |
| Great Point Partners Llc | 3.07% | 1,000,000 | $13,040,000 | — | — | — | |
| Affinity Asset Advisors, Llc | 0.62% | 972,000 | $12,674,880 | — | — | — | |
| Millennium Management Llc | 0.01% | 908,198 | $11,842,902 | — | — | — | |
| Adar1 Capital Management, Llc | 0.50% | 822,649 | $10,727,343 | — | — | — | |
| Driehaus Capital Management Llc | 0.06% | 790,000 | $10,301,600 | — | — | — | |
| Geode Capital Management, Llc | 0.00% | 782,199 | $10,202,039 | — | — | — | |
| Stempoint Capital Lp | 1.68% | 742,745 | $9,685,395 | — | — | — | |
| State Street Corp | 0.00% | 686,772 | $8,955,507 | — | — | — | |
| Ameriprise Financial Inc | 0.00% | 657,971 | $8,579,978 | — | — | — | |
| Parkman Healthcare Partners Llc | 0.75% | 563,484 | $7,347,831 | — | — | — | |
| Superstring Capital Management Lp | 4.29% | 521,082 | $6,794,909 | — | — | — | |
| Sphera Funds Management Ltd. | 0.90% | 483,747 | $6,308,061 | — | — | — | |
| Invesco Ltd. | 0.00% | 373,445 | $4,869,724 | — | — | — | |
| Morgan Stanley | 0.00% | 365,088 | $4,760,747 | — | — | — | |
| Nan Fung Trinity (Hk) Ltd | 0.46% | 360,654 | $4,702,928 | — | — | — | |
| Northern Trust Corp | 0.00% | 330,290 | $4,306,981 | — | — | — | |
| Ikarian Capital, Llc | 0.64% | 300,000 | $3,912,000 | — | — | — | |
| Td Asset Management Inc | 0.00% | 267,102 | $3,483,010 | — | — | — | |
| Qube Research & Technologies Ltd | 0.00% | 266,649 | $3,477,103 | — | — | — | |
| Ally Bridge Group (Ny) Llc | 4.19% | 249,172 | $3,249,203 | — | — | — | |
| Vanguard Portfolio Management Llc | 0.00% | 239,657 | $3,125,127 | — | — | — | |
| Dimensional Fund Advisors Lp | 0.00% | 239,451 | $3,123,319 | — | — | — | |
| Vanguard Fiduciary Trust Co | 0.00% | 195,041 | $2,543,335 | — | — | — | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 192,700 | $2,512,808 | — | — | — |
| Boothbay Fund Management, Llc | 0.04% | 182,645 | $2,381,691 | — | — | — | |
| Fifth Third Bancorp | 0.00% | 164,923 | $2,150,596 | — | — | — | |
| Manufacturers Life Insurance Company, The | 0.00% | 164,712 | $2,147,844 | — | — | — | |
| Two Sigma Investments, Lp | 0.00% | 148,238 | $1,933,024 | — | — | — | |
| Jane Street Group, Llc | 0.00% | 131,761 | $1,718,163 | — | — | — | |
| Bridgeway Capital Management, Llc | 0.03% | 130,300 | $1,699,112 | — | — | — | |
| Archpoint Investors | 0.36% | 128,900 | $1,680,856 | — | — | — | |
| Schonfeld Strategic Advisors Llc | 0.01% | 126,138 | $1,644,838 | — | — | — | |
| Bank Of New York Mellon Corp | 0.00% | 123,658 | $1,612,501 | — | — | — | |
| Charles Schwab Investment Management Inc | 0.00% | 104,634 | $1,364,427 | — | — | — | |
| Wellington Management Group Llp | 0.00% | 96,807 | $1,262,364 | — | — | — | |
| Nuveen, Llc | 0.00% | 85,935 | $1,120,592 | — | — | — | |
| Goldman Sachs Group Inc | 0.00% | 83,230 | $1,085,319 | — | — | — |
Frequently asked questions about ELYM
Who owns the most ELYM stock?
The largest holders of ELYM are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ELIEM THERAPEUTICS INC (ELYM).
Is ELYM widely held by superinvestors?
Many widely followed stocks like ELYM appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ELYM is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.